
Westlake Chemical (WLK) reported a significant Q2 earnings miss, posting an EPS of $-1.11 against an analyst estimate of $0.09 and revenue of $2.95 billion, below the $3.01 billion consensus. This substantial underperformance, coupled with eight negative EPS revisions in the last 90 days and a nearly 47% stock price decline over the past year, highlights considerable operational challenges and raises concerns for the company's near-term outlook.
Westlake Chemical (WLK) reported a significant second-quarter operational failure, with an EPS of $-1.11, drastically missing analyst estimates of $0.09 by $1.20. The company also fell short on its top line, generating $2.95 billion in revenue against a consensus of $3.01 billion. This poor quarterly performance is consistent with a severe and prolonged negative trend, evidenced by the stock's -47.05% decline over the past 12 months and a -5.21% drop in the last three months. The bearish sentiment is further solidified by analyst outlook, with eight negative EPS revisions and zero positive revisions in the last 90 days, indicating that experts had already anticipated significant weakness. While the company's financial health is rated as merely "fair performance," the substantial earnings miss confirms the market's deep-seated concerns about its fundamental trajectory.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.80
Ticker Sentiment